Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 6998253 Altered polypeptides with increased half-life

Patent 6998253 was granted and assigned to Genentech on February, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
July 31, 2000
0
Date of Patent
February 14, 2006
0
Patent Application Number
09628568
0
Patent Citations Received
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
0
‌
US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment
0
‌
US Patent 12077790 Optimized binuclease fusions and methods
0
‌
US Patent 12134632 On-column viral inactivation methods
0
‌
US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof
0
‌
US Patent 11827701 IL-6 binding molecules
0
‌
US Patent 11879004 Modified binding polypeptides for optimized drug conjugation
0
Patent Inventor Names
Bradley R. Snedecor
0
Leonard G. Presta
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
6998253
0
Patent Primary Examiner
‌
David Saunders
0

Find more entities like US Patent 6998253 Altered polypeptides with increased half-life

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.